BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 773500)

  • 1. Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial.
    Berry H; Liyanage SP; Durance RA; Barnes CG; Berger LA; Evans S
    Br Med J; 1976 May; 1(6017):1052-4. PubMed ID: 773500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azathioprine versus D-penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with gold.
    Paulus HE; Williams HJ; Ward JR; Reading JC; Egger MJ; Coleman ML; Samuelson CO; Willkens RF; Guttadauria M; Alarcón GS
    Arthritis Rheum; 1984 Jul; 27(7):721-7. PubMed ID: 6378208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis.
    Hansen TM; Kryger P; Elling H; Haar D; Kreutzfeldt M; Ingeman-Nielsen MW; Olsson AT; Pedersen C; Rahbek A; Tvede N
    BMJ; 1990 Aug; 301(6746):268-70. PubMed ID: 2202458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.
    Neumann VC; Grindulis KA; Hubball S; McConkey B; Wright V
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1099-102. PubMed ID: 6138116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interim observations on benefit/risk of azathioprine versus D-penicillamine in the treatment of rheumatoid arthritis.
    Ward JR; Williams HJ
    Ann Rheum Dis; 1982; 41 Suppl 1(Suppl 1):23-5. PubMed ID: 6802080
    [No Abstract]   [Full Text] [Related]  

  • 6. Alclofenac and D-penicillamine. Comparative trial in rheumatoid arthritis.
    Berry H; Fernandes L; Ford-Hutchinson AW; Evans SJ; Hamilton EB
    Ann Rheum Dis; 1978 Feb; 37(1):93-7. PubMed ID: 24426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind trial of levamisole, penicillamine and azathioprine in rheumatoid arthritis. Clinical, biochemical, radiological and scintigraphic studies.
    Halberg P; Bentzon MW; Crohn O; Gad I; Halskov O; Heyn J; Ingemann M; Junker P; Lorenzen I; Møller I
    Dan Med Bull; 1984 Oct; 31(5):403-9. PubMed ID: 6391849
    [No Abstract]   [Full Text] [Related]  

  • 8. Controlled multicenter trial of tiopronin and d-penicillamine for rheumatoid arthritis.
    Pasero G; Pellegrini P; Ambanelli U; Ciompi ML; Colamussi V; Ferraccioli G; Barbieri P; Mazzoni MR; Menegale G; Trippi D
    Arthritis Rheum; 1982 Aug; 25(8):923-9. PubMed ID: 7115451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine in 50 rheumatoid arthritic patients intolerant or unresponsive to gold or penicillamine.
    Jenkins EA; Ansell BM; Hall MA; Liyanage SP
    Clin Rheumatol; 1985 Sep; 4(3):278-80. PubMed ID: 4064585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial comparing azathioprine and penicillamine in treatment of rheumatoid arthritis [proceedings].
    Berry H; Liyanage S; Durance R; Barnes CG; Berger L
    Ann Rheum Dis; 1976 Dec; 35(6):542-3. PubMed ID: 795387
    [No Abstract]   [Full Text] [Related]  

  • 11. Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.
    Huskisson EC; Gibson TJ; Balme HW; Berry H; Burry HC; Grahame R; Hart FD; Henderson DR; Wojtulewski JA
    Ann Rheum Dis; 1974 Nov; 33(6):532-5. PubMed ID: 4216306
    [No Abstract]   [Full Text] [Related]  

  • 12. [Long term treatment of rheumatoid arthritis. Experiences with D-penicillamine in comparison with gold and immunosuppressive drugs (author's transl)].
    Warnatz H; Scheiffarth F; Gutmann W
    Med Klin; 1975 Sep; 70(38):1509-15. PubMed ID: 810648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
    Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA
    J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of three controlled trials.
    Dahl SL; Samuelson CO; Williams HJ; Ward JR; Karg M
    Pharmacotherapy; 1990; 10(2):79-84. PubMed ID: 2112243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis--a comparative study.
    Gibson T; Emery P; Armstrong RD; Crisp AJ; Panayi GS
    Br J Rheumatol; 1987 Aug; 26(4):279-84. PubMed ID: 3300834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penicillamine in the treatment of rheumatoid arthritis.
    Huskisson EC; Hart FD
    Ann Rheum Dis; 1972 Sep; 31(5):402-4. PubMed ID: 5071635
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of rheumatoid arthritis with penicillamine.
    Hill HF
    Semin Arthritis Rheum; 1977 May; 6(4):361-88. PubMed ID: 323979
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlled trial of D-penicillamine in rheumatoid arthritis. Dose effect and the role of zinc.
    Mery C; Delrieu F; Ghozlan R; Saporta L; Simon F; Amor B; Menkes CJ; Delbarre F
    Scand J Rheumatol; 1976; 5(4):241-7. PubMed ID: 795022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levamisole in rheumatoid arthritis: a comparison with D-penicillamine.
    Mowat AG; Mowat AM
    J Rheumatol; 1981; 8(4):575-80. PubMed ID: 7299760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-modifying drugs for progressive rheumatoid arthritis.
    Bunch TW; O'Duffy JD
    Mayo Clin Proc; 1980 Mar; 55(3):161-79. PubMed ID: 6766523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.